Evidence map›Paper›PMID 42109387›Full record

ArticleBioinformation2026

QT interval prolongation and heart failure severity: A longitudinal study.

Mani Shankar Pandey, Jyoti Mani Shankar Pandey

Abstract read
In one paragraph

Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mani Shankar PandeyDepartment of Cardiology, Nalanda Medical College and Hospital, Patna, Bihar, India.
Jyoti Mani Shankar PandeyDepartment of Ophthalmology, Nalanda Medical college and Hospital, Patna, Bihar, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HFrEF or HFpEF) patients are at risk for arrhythmic events and mortality, yet the role of QT interval prolongation as a prognostic marker in this population remains poorly understood. Patients with heart failure (HFrEF or HFpEF) were assessed for changes in QT interval, NYHA class, LVEF, BNP levels and hospitalizations. Results showed significant associations between prolonged QT interval and worsening heart failure, with increased risks of arrhythmic events and mortality. The advancement to knowledge in this study is the identification of QT interval prolongation as a significant prognostic marker for heart failure severity.

Indexed as

Arrhythmic eventsheart failureleft ventricular ejection fractionmortalityQT interval prolongation

Identifiers

PMID42109387
PMCPMC13150283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.